1. Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
   Xun Chen et al, 2020, Metabolites CrossRef
2. Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development
   Kevin Dzobo et al, 2021, OMICS: A Journal of Integrative Biology CrossRef
3. Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
   Eun-Kyung Kim et al, 2019, Antioxidants CrossRef
4. The relationship between tumor metabolism and 5-fluorouracil resistance
   Jingyi Hu et al, 2023, Biochemical Pharmacology CrossRef
5. In vitro 5-Fluorouracil resistance produces enhanced photodynamic therapy damage in SCC and tumor resistance in BCC
   Jimena Nicolás-Morala et al, 2022, Journal of Photochemistry and Photobiology B: Biology CrossRef
6. Development and Validation of an ADME-Related Gene Signature for Survival, Treatment Outcome and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma
   Xinran Tang et al, 2022, Frontiers in Immunology CrossRef
7. Anagliptin promotes apoptosis in mouse colon carcinoma cells via MCT‑4/lactate‑mediated intracellular acidosis
   Qi Li et al, 2022, Experimental and Therapeutic Medicine CrossRef
8. Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS–STAT3 pathway
   Di Chen et al, 2022, Journal of International Medical Research CrossRef
9. Assessment of Early Growth Response 1 in Tumor Suppression of Esophageal Squamous Cell Carcinoma
   Yen-Chiang Tseng et al, 2022, Journal of Clinical Medicine CrossRef
10. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells
    Liang Liu et al, 2017, Pathology - Research and Practice CrossRef
11. Drug metabolizing enzymes and their inhibitors' role in cancer resistance
    Shelly Pathania et al, 2018, Biomedicine & Pharmacotherapy CrossRef
12. Advances and challenges in the treatment of esophageal cancer
    Shiming He et al, 2021, Acta Pharmaceutica Sinica B CrossRef
13. Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinoma
    Yuan Qu et al, 2023, Oncology Letters CrossRef
14. Reactive oxygen species and colorectal cancer
    Sisi Lin et al, 2018, Journal of Cellular Physiology CrossRef
15. Downregulation of long non‐coding RNA LOC101928477 correlates with tumor progression by regulating the epithelial‐mesenchymal transition in esophageal squamous cell carcinoma
    Demiao Kong et al, 2021, Thoracic Cancer CrossRef
16. Cancer Drug Resistance and Metabolic Reprogramming
    Shariqa Jan et al, 2024, Drug Resistance in Cancer: Mechanisms and Strategies CrossRef
17. Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer
    Rong-Yao Li et al, 2022, Chemico-Biological Interactions CrossRef
18. Tumor‐derived extracellular vesicles confer 5‐fluorouracil resistance in esophageal cancer via long noncoding RNA AC116025.2 delivery
    Shuyao Zhang et al, 2022, Molecular Carcinogenesis CrossRef